01:33 , Sep 13, 2014 |  BC Extra  |  Financial News

Affimed raises $56M in IPO

Affimed Therapeutics B.V. (NASDAQ:AFMD) was down $1.30 to $5.70 on its first day of trading Friday after raising $56 million through the sale of 8 million shares at $7 in an IPO. The IPO price...
07:00 , Mar 17, 2014 |  BC Week In Review  |  Company News

Formycon, Santo Holding GmbH deal

In December, Formycon (formerly Nanohale AG ) granted investment holding company Santo exclusive, worldwide rights to develop and commercialize an undisclosed biosimilar product. This is the biosimilar company's first licensing deal. Formycon will conduct all...
08:00 , Jan 16, 2012 |  BC Week In Review  |  Company News

Nanohale, Scil Technology deal

Nanohale acquired Scil Technology for an undisclosed sum. Scil will become part of Nanohale's newly-formed Formycon GmbH subsidiary. Nanohale said that Scil Technology's protein drug development, formulation and analytics programs complement Nanohale's existing protein formulation....